BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Deals

  GSK Acquires Sierra in $1.9B Complimentary Deal Aimed at Rare Cancers

  GSK is acquiring Sierra Oncology for $1.9 billion in a deal expected to help both companies take a major step in developing a treatment for rare types of cancer.

  April 13, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Aadi, SOTIO and Ikena Target Cancer-Causing Mutations at AACR

  This year’s AACR Annual Meeting is coming to a close, and there has been a wealth of information and data presented. One topic of discussion stood out—mutations.

  April 13, 2022

   · 

  8 min read

   · 

  Rosemary Scott
• 

  Business

  Global Roundup: A CAR-T Partnership and CDR-Life Nabs $76M to Engage Solid Tumors

  Australia’s Chimeric Therapeutics has partnered with WuXi ATU on two autologous CAR T-cell therapies for solid tumors. Switzerland-based CDR-Life closed a $76 million Series A.

  April 13, 2022

   · 

  6 min read

   · 

  Alex Keown
• 

  Business

  Flagship Caps Busy Week with Addition of AbbVie’s Michael Severino

  Cambridge, Massachusetts-based life sciences firm Flagship Pioneering announced that Michael Severino, who will leave AbbVie on May 31, is joining Flagship as a CEO-Partner.

  April 13, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  CureDuchenne is Filling the Therapeutic Pipeline with Next Generation DMD Treatments

  Companies like Chameleon Biosciences and Code Biotherapeutics will present their latest research at the FUTURES 2022 conference hosted by CureDuchenne.

  April 13, 2022

   · 

  5 min read

   · 

  Abbey Glasure
• 

  Job Trends

  AbbVie, Others Spring Into New Real Estate, Personnel Investments

  With Spring comes new beginnings, and companies within the biopharmaceutical industry are blossoming with fresh ventures. Here are some of them:

  April 13, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano
• 

  Drug Development

  Study Calls into Question Link Between COVID-19 Vaccines and Myopericarditis

  Reports that myopericarditis may be a side effect of COVID-19 vaccination are downplayed by a recently published study that suggests there might not be a correlation.

  April 13, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, MS
• 

  Business

  Halozyme Picks Up Antares’ Drug Delivery Tech for Nearly $1B

  Halozyme Therapeutics announced that it is acquiring Antares Pharma for $960 million in cash. The news caused Antares stock to rocket 47% in premarket trading.

  April 13, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Deals

  Legal Fees for Shkreli, Holmes, Purdue Go Unpaid as Cases Unfold

  As Martin Shkreli, Elizabeth Holmes and Sunny Balwani, and the Purdue bankruptcy deal play out, there is even more drama beyond the stories–a failure to pay legal fees.

  April 13, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  FDA Cracks Down on Illegal Sales of Adderall, CBD Claims

  The FDA has sprung into action, cracking down on the illegal sales of Adderall, as well as on CBD companies making claims their products are effective treatments or cures for COVID-19.

  April 13, 2022

   · 

  3 min read

   · 

  Alex Keown